anemodeanin a has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Jin, Z; Li, Z; Qian, J; Tang, X; Teng, Y; Wang, R; Xing, Y; Xue, W | 1 |
Cao, X; Jiang, Y; Lin, L; Luo, X; Wu, X | 1 |
Cai, R; Chen, M; Li, G; Li, L | 1 |
3 other study(ies) available for anemodeanin a and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Raddeanin A promotes autophagy-induced apoptosis by inactivating PI3K/AKT/mTOR pathway in lung adenocarcinoma cells.
Topics: Adenocarcinoma of Lung; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Raddeanin A Improves the Therapeutic Effect of Osimertinib in NSCLC by Accelerating ROS/NLRP3-mediated Pyroptosis.
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Mutation; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Pyroptosis; Reactive Oxygen Species | 2023 |
Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Proteins; Reactive Oxygen Species; Saponins; STAT3 Transcription Factor | 2021 |